L-168049

Research use only, not for human use.

human glucagon receptor (hGR) antagonist.

human glucagon receptor (hGR) antagonist(In Vitro):In Chinese hamster ovary cells expressing the human glucagon receptor, L-168049 increases the apparent EC50 of glucagon-stimulated adenylate cyclase and decreases maximal glucagon stimulation with a Kb of 25 nM. L-168049 blocks glucagon-stimulated cAMP formation in mouse liver membrane and inhibits glucagon (100 pM)-stimulated cAMP synthesis in CHO cells expressing the human glucagon receptor with IC50 of 41 nM .(In Vivo):In the liver of L-G6pc-/- mice, L-168049 (50 mg/kg body; p.o.) reduces Pck1 mRNA expression by half within 6 hours. L-168049 prevents the increase in G6pc expression in the kidney and gut .

L-168,049

Others

Other Targets

——

——

——

191034-25-0

467.8

C24H20BrClN2O

>98% (HPLC)

——

CCCOc1ccc(Br)cc1-c1cc([nH]c1-c1ccncc1)-c1ccc(Cl)cc1

——

(-20℃)

With Ice Pack

≥ 2 years